Glioma: molecular signature and crossroads with tumor microenvironment

In patients with glioblastoma, the average survival time with current treatments is short, mainly due to recurrences and resistance to therapy. This insufficient treatment success is, in large parts, due to the tremendous molecular heterogeneity of gliomas, which affects the overall prognosis and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Barthel, Lennart, Hadamitzky, Martin, Dammann, Philipp, Schedlowski, Manfred, Sure, Ulrich, Thakur, Basant Kumar, Hetze, Susann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924130/
https://www.ncbi.nlm.nih.gov/pubmed/34687436
http://dx.doi.org/10.1007/s10555-021-09997-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924130/
https://www.ncbi.nlm.nih.gov/pubmed/34687436
http://dx.doi.org/10.1007/s10555-021-09997-9

Ejemplares similares